Caspofungin Acetate Injection, Powder, Lyophilized, For Solution
FDA Label NDC 69806-0092

The following Structured Product Label (SPL) was submitted to the FDA by Merck Sharp & Dohme Corp. for the product Caspofungin Acetate (NDC 69806-0092). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding principal display panel - shipping label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel - Shipping Label

MATERIAL 2004223

CASPOFUNGIN ACETATE
SUBDIVIDED GRAMS
1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N²-(10,12-dimethy-1-oxotetradecyl)-4-hydroxy-L-ornithine]-
5-[(3R)-3-hydroxy-L-ornithine]pneumocandin B₀ diacetate (salt)
CAS 179463-17-3

STORAGE: Must be stored at -70°C (-94°F).

SHIPPING: Temperature must not exceed -20°C (-4°F) during shipping.

CAUTION: For manufacturing, processing or repacking.

Rx only

Made in USA

BATCH
RETEST DATE
NET WEIGHT

KK _KK
Merck Sharp & Dohme Corp., Elkton, Virginia 22827, USA

Shipping Label (Caspofungin 01)

* Please review the disclaimer below.